Table 1. Demographic information of our human postmortem samples.
Cohort | Number | Race | Sex | Age | PMI(h) | pH | RIN |
---|---|---|---|---|---|---|---|
Controls | 326 | 117AA/107CAUC/6HISP/6AS | 167M/69F | 41±17.1 | 29.3±14.5 | 6.55±0.28 | 8.30±0.69 |
SZ patients | 176 | 73AA/96CAUC/4HISP/3AS | 111M/65F | 50±15 | 38.6±24.1 | 6.40±0.25 | 7.84±0.96 |
BP patients | 61 | 6AA/51CAUC/1HISP/3AS | 36M/25F | 45±14 | 32.9±18.4 | 6.36±0.28 | 7.99±0.86 |
MDD patients | 138 | 14AA/119CAUC/3HISP/2AS | 79M/59F | 45±14 | 37.8±28.3 | 6.35±0.28 | 8.03±0.88 |
Lifespan | |||||||
Fetal Controls | 43 | 37AA/5CAUC/1HISP | 22M/21F | -0.42±0.07a | 2.58±2.14 | N/A | 8.81±1.29 |
Postnatal Controls | 283 | 139AA/132CAUC/6HISP/6AS | 198M/85F | 34.99±20.84 | 28.9±14.4 | 6.52±0.30 | 8.22±0.79 |
AA, African American; CAUC, Caucasian; AS, Asian; HISP, Hispanic; F, Female; M, Male; Sz, Schizophrenia; BP, Bipolar Disorder; MDD, Major Depressive Disorder; PMI, Postmortem Interval; RIN, RNA Integrity Number.
aFetal cohort in gestational age in weeks.